Power Law company profile

Rocket Pharmaceuticals

Biotech & Life Sciences · Cranbury Township, United States · Founded 2015 · IPO 2018 Unicorn

Rocket Pharmaceuticals Ltd operates in the healthcare industry focusing on biotechnology business

Valuation

$216M

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Global footprint

Where Rocket Pharmaceuticals has talent and traffic

Workforce by country

6 countries with
team presence

🇺🇸 United States93.8%

🇪🇸 Spain3.9%

🇸🇪 Sweden1%

🇳🇱 Netherlands0.5%

🇩🇪 Germany0.5%

Top 5 of 6 shown

Web traffic by country

21K monthly visits
across markets

🇺🇸 United States81%

🇬🇧 United Kingdom7.6%

🇮🇳 India7.1%

🇵🇭 Philippines2.4%

Top 4 markets shown

Patent intelligence

$4M patent portfolio · 5 active families

Estimated portfolio value

$4M

1.8% of market cap · 509.2× smaller than top peer Ablynx ($2B)

5 active patent families

Where Rocket Pharmaceuticals innovates Molecular biologyCell biologyMedicinePolynucleotideGene Modification

Where Rocket Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Rocket Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Rocket Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Rocket Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rocket Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles